Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anthony Dailley currently holds 285,259 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony Dailley has been a net buyer of NBY stock. They have purchased $8.3K and sold $0 worth of shares.
Anthony Dailley's most recent insider trade was on Mar 17, 2014, when they sold 9,000 shares at $0.56 per share.
Anthony Dailley serves as Executive at NovaBay Pharmaceuticals, Inc. (NBY). They have executed 33 insider transactions totaling $8.3K over their tenure at the company.
Anthony Dailley holds the position of Executive at NovaBay Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Anthony Dailley has shown a buying trading pattern, with $8.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Anthony Dailley was on Aug 28, 2008, when they purchased $8.4K worth of NBY shares. This transaction involved 15,000 shares at $0.56 per share.
Anthony Dailley currently owns 285,259 shares of NovaBay Pharmaceuticals, Inc. (NBY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anthony Dailley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anthony Dailley has 33 Form 4 filings on record as an insider at NovaBay Pharmaceuticals, Inc..
Set alerts for Anthony Dailley and 40,000+ other insiders.